Industry
Pharmaceuticals market research
Brand, pipeline and portfolio research for global and generic pharma companies.
HealthcareMarketResearch runs pharmaceuticals market research for global leaders, challengers and investors. Our 5,000+ researchers include practising clinicians, procurement leaders, payers and former executives from the pharmaceuticals industry.
Studies combine expert calls, qualitative interviews and quantitative surveys, so you can size the opportunity, understand stakeholders and plan go-to-market with confidence.
Topics we research
- Prescribing drivers
- Formulary access
- Launch tracking
- Lifecycle management
Relevant services
At a glance
Pharmaceuticals market research at a glance
The audiences, methods and timelines a typical pharmaceuticals study runs on.
- Audiences
- Prescribing specialists and general physicians, hospital and retail pharmacists, P&T and formulary committee members, payer medical directors, brand and market access leads, stockists and trade partners
- Typical methods
- Expert calls, prescriber surveys, patient chart and record reviews, message testing, advisory boards and launch trackers
- Research focus
- prescribing drivers · formulary access · launch tracking · lifecycle management
- Geography
- 100+ Indian cities, metro and tier 2, plus global peer benchmarks
- Expert matching
- 24–48 hours from a confirmed brief
- Fieldwork window
- 5–10 business days for most interview and survey studies
- Core outputs
- Prescriber segmentation, message and claim performance, formulary and access barriers, competitor positioning and a tracked launch dashboard
- Regulatory context
- Studies respect CDSCO, FDA and EMA labelling and promotional constraints, and run under EphMRA and BHBIA codes.
Scope, sample and timings are confirmed in writing before fieldwork starts.
Why teams commission it
Decisions pharmaceuticals research supports
Each brief starts from the decision it has to inform, so the readout answers the question your team is actually facing.
Brand positioning
Which claims and messages change prescribing intent, and which are already owned by a competitor.
Portfolio and lifecycle moves
Where a new formulation, indication or fixed-dose combination earns its place, and what it cannibalises.
Pricing and formulary access
What committees, payers and pharmacy buyers will fund, and the evidence they request before listing.
Launch sequencing
Which specialties, accounts and cities to lead with, and what has to be in place before the field force arrives.
In-market diagnosis
Why share is moving, where scripts leak at the pharmacy counter and which switching triggers can be influenced.
Field and channel design
Call plan priorities, MSL focus and the trade and distribution model your brand needs to be available.
Stakeholders
Who we reach in pharmaceuticals
We recruit the people who make and influence the decision — not only the easiest audience to find. Every expert is screened for recency of practice and conflicts of interest.
Prescribers
- High-volume specialists in the therapy area
- General and family physicians
- Consultants across private and government hospitals
- Residents and junior prescribing staff
Pharmacy and formulary
- Hospital and specialty pharmacists
- P&T and formulary committee members
- Retail pharmacy chain category heads
- Stockists, distributors and trade partners
Commercial and access
- Brand, portfolio and marketing leads
- Market access, pricing and HEOR teams
- Medical affairs and MSL teams
- Payer medical directors and HTA assessors
How it runs
A pharmaceuticals research programme, stage by stage
Senior researchers at our Pune, Maharashtra, India headquarters design, moderate and analyse every study.
- 01
Brief and brand question
We agree the brand, access or launch decision at stake, then design the screener, stimulus and questionnaire around the label and the competitive set.
Scoped in writing
- 02
Prescriber and pharmacy recruitment
We recruit specialists, physicians, pharmacists and formulary members, screening on patient volume, specialty and prescribing recency.
24–48 hours
- 03
Fieldwork and stimulus testing
Interviews, surveys and message tests run with promotional compliance and adverse event rules written into the guide.
5–10 business days
- 04
Readout and tracking
We deliver prescriber segments, message performance and access barriers, and can repeat the same instrument as a launch tracker.
Report and debrief
Compliance
Standards every pharmaceuticals study runs under
Compliance is designed into the screener and the guide, not bolted on at the end.
Research codes
pharmaceuticals guides follow EphMRA, BHBIA and Insights Association standards, including adverse event and off-label handling.
Regulatory framing
Studies respect CDSCO, FDA and EMA labelling and promotional constraints, and run under EphMRA and BHBIA codes.
Data protection
Recruitment, transcripts and data files are handled under GDPR, HIPAA and India's DPDP Act, with pseudonymised outputs.
Conflict screening
Every expert is screened for employer restrictions, confidentiality obligations and conflicts of interest before a session is confirmed.
FAQs
Pharmaceuticals market research questions
What is pharmaceutical market research?+
Pharmaceutical market research is primary research with prescribers, pharmacists, formulary committees and payers to guide brand, pipeline and portfolio decisions. HealthcareMarketResearch covers prescribing drivers, formulary access, launch tracking and lifecycle management.
Can you reach prescribers across India?+
Yes. We recruit specialists and physicians across 100+ Indian cities, from metro corporate hospitals to tier 2 and tier 3 practices, with fieldwork in English, Hindi and major regional languages.
How do you research formulary and access decisions?+
We interview hospital pharmacists, P&T and formulary committee members, payer medical directors and HTA assessors, testing the evidence and pricing scenarios that determine whether a product is listed and under what conditions.
Can you track a launch over time?+
Yes. We run the same screener and instrument in repeat waves so awareness, trial, adoption and message recall are comparable wave on wave, with expert calls layered in when a result needs explaining.
How do you handle promotional and off-label rules?+
Stimulus is reviewed against the approved label before fieldwork, off-label questioning follows EphMRA and BHBIA guidance, and adverse events are reported through your pharmacovigilance route within the agreed window.
Coverage
Where we run pharmaceuticals research in India
Studies are designed and analysed at our Pune, Maharashtra, India headquarters, with recruitment and fieldwork across 100+ Indian cities — metro, tier 2 and tier 3.
All industries
Explore the other 24 healthcare segments
Grouped by the kind of organisation or therapy area you work in, so you can find the neighbouring page quickly.
Life sciences companies
Therapy areas
Care delivery, payers and technology
Have a healthcare question that needs real answers?
Brief us today and talk to a verified expert this week.